M. Casanova

发表

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

F. Prósper, A. Órfão, N. Puig, 2018, Leukemia.

Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma

E. Alba, M. Casanova, A. Rueda, 2021, International Journal of Hematology.

Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?

M. Redondo, M. Casanova, E. Pérez-Ruiz, 2012, BMC Cancer.

Multiple Myeloma Treatment in Real‐world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Jesús Martín Sánchez, M. Beksac, H. Goldschmidt, 2018, Clinical lymphoma, myeloma & leukemia.

Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma

M. Moreno-Beltrán, M. Casanova, A. Rueda, 2011, Therapeutics and clinical risk management.

Pralatrexate, a new hope for aggressive T-cell lymphomas?

M. Casanova, A. Rueda, C. Quero, 2009, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chronic Clonal Proliferative Disease of Gamma-Delta (γδ) T-cells in a Patient with Rheumatoid Arthritis and Neutropenia: Lack of the Morphology and the Immunophenotype of Large Granular Lymphocytes

M. Casanova, I. Pérez Sánchez, J. Lopez Longo, 2004, Leukemia & lymphoma.

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

F. Prósper, N. Puig, A. Oriol, 2020, Leukemia.

Treatment of childhood Hodgkin's disease with COPP or COPP-ABV (hybrid) without radiotherapy in Nicaragua.

F. Cavalli, C. Sessa, G. Masera, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

E. Giné, A. López-Guillermo, E. Campo, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FUSARIUM SOLANI SUBRETINAL ABSCESS IN A PATIENT WITH ACUTE MYELOID LEUKEMIA

M. Casanova, A. Schlaen, M. Saravia, 2016, Retinal cases & brief reports.

Recent HIV infection complicated with leukocytoclastic vasculitis and oligoarthritis.

Y. Pers, M. Casanova, C. Jorgensen, 2014, Medecine et maladies infectieuses.

Has the time to come leave the “watch-and-wait” strategy in newly diagnosed asymptomatic follicular lymphoma patients?

M. Redondo, M. Casanova, E. Pérez-Ruiz, 2012, BMC Cancer.

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance–Like Phenotype in Patients With Monoclonal Gammopathies

A. Órfão, N. Puig, P. Milani, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma.

H. Goldschmidt, F. Prósper, A. Órfão, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor cells in light-chain amyloidosis and myeloma show different transcriptional rewiring of normal plasma cell development.

I. Amit, A. Weiner, F. Prósper, 2021, Blood.

A phase II study to evaluate lenalidomide in combination with metronomic-dose cyclophosphamide in patients with heavily pretreated classical Hodgkin lymphoma

A. Salar, M. Provencio, J. Labrador, 2015, Acta oncologica.

Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

V. Calvo, M. Provencio, D. Rodríguez-Abreu, 2018, Leukemia & lymphoma.

Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients

I. Buño, C. Castellares, C. Radice, 2006, Leukemia & lymphoma.

Role of vascular endothelial growth factor C in classical Hodgkin lymphoma

M. Provencio, E. Alba, M. Mendiola, 2015, Leukemia & lymphoma.

Paraneoplastic pruritus presenting with Hodgkin’s lymphoma: a case report

M. Casanova, A. R. Domínguez, B. T. Goitia, 2014, Journal of Medical Case Reports.

Use of quantitative susceptibility mapping (QSM) in progressive multifocal leukoencephalopathy.

A Makinson, J. Deverdun, N. Menjot de Champfleur, 2016, Journal of neuroradiology. Journal de neuroradiologie.

[Clinical characterization of patients with multiple sclerosis defined in Cuba].

J. Cabrera-Gomez, M. Casanova, A. González-Quevedo, 1998, Revista de neurología (Ed. impresa).

Randomized Phase 2 Study of Weekly Carfilzomib 70 Mg/m2 and Dexamethasone Plus/Minus Cyclophosphamide in Relapsed and/or Refractory Multiple Myeloma (RRMM) Patients (GEM-KyCyDex)

A. Oriol, E. Ocio, J. San-Miguel, 2020 .

OAB-035: Minimally invasive profiling of tumor and immune cells to stratify risk in smoldering multiple myeloma (SMM): the iMMunocell study

H. Goldschmidt, R. Hájek, H. Avet-Loiseau, 2021, Clinical Lymphoma, Myeloma & Leukemia.

Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial

N. Puig, M. Calasanz, A. Oriol, 2021, Blood Cancer Journal.

Clonal architecture and evolutionary history of Waldenström's macroglobulinemia at the single-cell level

E. Askari, M. Sarasquete, R. García-Sanz, 2023, Disease models & mechanisms.